Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 21, 2023

SELL
$79.22 - $105.37 $260,396 - $346,351
-3,287 Reduced 9.67%
30,693 $3.13 Million
Q1 2023

May 09, 2023

SELL
$30.85 - $93.17 $12,895 - $38,945
-418 Reduced 1.22%
33,980 $3.09 Million
Q4 2022

Feb 14, 2023

BUY
$22.15 - $42.11 $9,147 - $17,391
413 Added 1.22%
34,398 $1.31 Million
Q3 2022

Nov 18, 2022

SELL
$19.41 - $36.49 $12,868 - $24,192
-663 Reduced 1.91%
33,985 $854,000
Q2 2022

Aug 15, 2022

BUY
$20.71 - $36.5 $1,242 - $2,190
60 Added 0.17%
34,648 $1.05 Million
Q1 2022

May 16, 2022

SELL
$24.12 - $39.6 $69,465 - $114,048
-2,880 Reduced 7.69%
34,588 $1.13 Million
Q4 2021

Feb 15, 2022

BUY
$25.61 - $110.96 $20,897 - $90,543
816 Added 2.23%
37,468 $988,000
Q3 2021

Nov 15, 2021

SELL
$100.0 - $143.02 $118,500 - $169,478
-1,185 Reduced 3.13%
36,652 $3.69 Million
Q2 2021

Aug 16, 2021

SELL
$78.27 - $151.29 $693,472 - $1.34 Million
-8,860 Reduced 18.97%
37,837 $5.36 Million
Q1 2021

May 18, 2021

BUY
$94.25 - $132.81 $330,817 - $466,163
3,510 Added 8.13%
46,697 $4.66 Million
Q4 2020

Feb 16, 2021

BUY
$102.03 - $184.62 $92,133 - $166,711
903 Added 2.14%
43,187 $5.34 Million
Q3 2020

Nov 17, 2020

BUY
$93.53 - $163.34 $147,496 - $257,587
1,577 Added 3.87%
42,284 $4.12 Million
Q2 2020

Aug 17, 2020

BUY
$126.3 - $176.56 $791,395 - $1.11 Million
6,266 Added 18.19%
40,707 $6.35 Million
Q1 2020

May 13, 2020

BUY
$124.16 - $247.74 $34,888 - $69,614
281 Added 0.82%
34,441 $4.97 Million
Q4 2019

Feb 14, 2020

BUY
$74.57 - $217.92 $215,358 - $629,352
2,888 Added 9.24%
34,160 $6.98 Million
Q3 2019

Nov 15, 2019

BUY
$71.26 - $95.75 $22,945 - $30,831
322 Added 1.04%
31,272 $2.51 Million
Q2 2019

Aug 14, 2019

BUY
$77.72 - $94.35 $156,450 - $189,926
2,013 Added 6.96%
30,950 $2.92 Million
Q1 2019

May 09, 2019

SELL
$51.9 - $101.79 $18,528 - $36,339
-357 Reduced 1.22%
28,937 $2.47 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $76.44 $33,595 - $52,667
689 Added 2.41%
29,294 $1.64 Million
Q3 2018

Nov 14, 2018

BUY
$35.64 - $92.06 $152,147 - $393,004
4,269 Added 17.54%
28,605 $2.34 Million
Q2 2018

Aug 14, 2018

BUY
$19.94 - $40.96 $136,489 - $280,371
6,845 Added 39.13%
24,336 $851,000
Q1 2018

May 15, 2018

SELL
$20.0 - $30.19 $8,680 - $13,102
-434 Reduced 2.42%
17,491 $359,000
Q4 2017

Feb 14, 2018

SELL
$22.39 - $33.27 $8,956 - $13,308
-400 Reduced 2.18%
17,925 $508,000
Q3 2017

Nov 13, 2017

BUY
$26.29 - $31.88 $481,764 - $584,201
18,325
18,325 $570,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.